Molecular modeling on porphyrin derivatives as β5 subunit inhibitor of 20S proteasome

Muhammad Arba1, Andry Nur-Hidayat1, Ruslin1

  • 1Faculty of Pharmacy, Halu Oleo University, Kendari, 93231, Indonesia.

Insights

New porphyrin derivatives show promise as proteasome inhibitors for cancer therapy. These compounds target the proteasome

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Medicinal Chemistry

Background:

  • The ubiquitin-proteasome system is vital for protein quality control.
  • Proteasome inhibition is a validated anticancer therapy strategy.
  • The proteasome's β5 subunit is a key target for therapeutic intervention.

Purpose of the Study:

  • To design and evaluate novel porphyrin derivatives as inhibitors of the proteasome β5 subunit.
  • To investigate the binding modes and stability of porphyrin-proteasome complexes.
  • To assess the binding affinities and key interactions driving porphyrin compound binding.

Main Methods:

  • Molecular docking simulations using AutoDock 4.2.
  • Molecular dynamics simulations using AMBER 14.
  • MM-PBSA free energy calculations to determine binding affinities.

Main Results:

  • Porphyrin derivatives exhibited stable binding to the proteasome with minor effects on protein residue fluctuation.
  • Binding affinities of selected compounds (mono-H2PyP, bis-H2PzP, tetra-H2PyP) were comparable to a known inhibitor (HU10).
  • Increased meso-substituents enhanced electrostatic interactions, favoring porphyrin binding.

Conclusions:

  • Porphyrin derivatives are effective inhibitors of the proteasome β5 subunit.
  • Electrostatic and van der Waals interactions are crucial for porphyrin-proteasome binding.
  • These findings support the development of porphyrin-based therapeutics for cancer treatment.

Related Concept Videos

The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.3K
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.7K
The Proteasome02:18

The Proteasome

4.6K
Molecular Models02:00

Molecular Models

Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
43.9K
Protein Complex Assembly02:41

Protein Complex Assembly

Proteins can form homomeric complexes with another unit of the same protein or heteromeric complexes with different types.  Most protein complexes self-assemble spontaneously via ordered pathways, while some proteins need assembly factors that guide their proper assembly. Despite the crowded intracellular environment, proteins usually interact with their correct partners and form functional complexes.
Many viruses self-assemble into a fully functional unit using the infected host cell to...
16.9K
The Proteasome Structure01:17

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
1.8K